Delivery Order SPE2DB25D3017-SPE2DB25FVKEC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,129.63 to AmerisourceBergen Drug Corp for the supply of Anucort-HC 25 mg suppositories (24-count packages) on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Anucort-HC 25 mg suppositories (24-count packages) valued at $1,360.02. This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,160.30 to AmerisourceBergen Drug Corp on January 12, 2026, for the supply of Anucort-HC 25 mg suppositories (24-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation. Performance will be completed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 13, 2026. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Anucort-HC 25 mg suppository (24 count) with a ceiling value of $1,960.18. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 23, 2026. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc.,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Anucort-HC 25 mg suppositories (24-count packaging) on July 28, 2025, with a contract ceiling value of $2,720.04. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award status. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This delivery order...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,978.28 to AmerisourceBergen Drug Corp for Proctofoam 10GM, a topical pharmaceutical product. The award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, was competitively awarded without set-aside restrictions under a firm fixed-price contract type. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its...
- The Defense Logistics Agency awarded a $10,179.63 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Proctofoam 10GM, a pharmaceutical product used in medical treatment. This firm fixed-price delivery order, with an ultimate completion date of January 30, 2026, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a $1,077.91 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in a 10-gram quantity, with an ultimate completion date of May 7, 2025. This is a firm fixed price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product is being delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,097.80 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam 10GM, a pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of December 15, 2025, and was awarded on December 12, 2025. This is a non-set-aside award, indicating it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Department's Medical Supply Chain awarded a $4,919.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Proctofoam 10GM (a topical hemorrhoid treatment). This is a non-set-aside competitive award with an ultimate completion date of October 10, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle with the Defense Logistics Agency. The work will be performed at the contractor's corporate...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKECDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,819.94 to AmerisourceBergen Drug Corp for Proctocort 30 mg suppositories (12-count packages) with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, issued on August 8, 2025, carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order represents a discrete fulfillment under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement valued through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies globally to support military healthcare programs. The company's federal contract portfolio demonstrates extensive experience delivering a diverse range of pharmaceutical products and medical supplies through competitively awarded delivery orders with firm fixed pricing, positioning it as a key supplier for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 8/8/25 |